Search results
Results from the WOW.Com Content Network
Sacubitril/valsartan, sold under the brand name Entresto among others, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan .
An unusual side effect of digoxin is a disturbance of color vision (mostly yellow and green) called xanthopsia. Vincent van Gogh's "Yellow Period" may have somehow been influenced by concurrent digitalis therapy. Other oculotoxic effects of digoxin include generalized blurry vision, as well as seeing a "halo" around each point of light.
They may include vomiting, loss of appetite, confusion, blurred vision, changes in color perception, and decreased energy. [1] Potential complications include an irregular heartbeat, which can be either too fast or too slow. [1] Toxicity may occur over a short period of time following an overdose or gradually during long-term treatment. [1]
Medicare Part D usually covers Entresto. However, the exact cost of Entresto can vary. In 2022, according to the most recent data, the annual out-of-pocket cost for Entresto for people with ...
The judge also rejected Novartis' argument that a ruling against the company would cause "irreparable harm" by triggering a wave of generic Entresto launches by other drugmakers.
There have been some anecdotal reports suggesting that weight loss drugs may be linked to vision problems, including blurred or warped vision. Rizzo said it’s unclear how the weight loss drugs ...
Alcohol intoxication can cause blurred vision. Use of cycloplegic drugs like atropine [4] or other anticholinergics cause visual blur due to paralysis of accommodation. [3] Cataracts: Cloudiness over the eye's lens, cause blurring of vision, halos around lights, and sensitivity to glare. [5] It is also the main cause of blindness worldwide. [2 ...
In 2022, Medicare beneficiaries taking Entresto had an average out-of-pocket cost of $357. Additional costs include premiums and deductibles. In 2022, Medicare beneficiaries taking Entresto had an ...